Final report from the analysis of candidate gene markers and genome-wide single nucleotide polymorphisms (SNPs) from two retrospective, case-control studies and three controlled clinical studies to investigate genetic polymorphisms in HIV infected subjects who developed hypersensitivity following treatment with abacavir
Latest Information Update: 22 Aug 2023
At a glance
- Drugs Abacavir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacogenomic
- Sponsors GlaxoSmithKline; GSK
- 07 Aug 2007 New trial record.